Cargando…

2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension

The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been established. It is confirmed that higher blood pressure levels are associated with increased ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyeon Chang, Ihm, Sang-Hyun, Kim, Gheun-Ho, Kim, Ju Han, Kim, Kwang-il, Lee, Hae-Young, Lee, Jang Hoon, Park, Jong-Moo, Park, Sungha, Pyun, Wook Bum, Shin, Jinho, Chae, Shung Chull
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670210/ https://www.ncbi.nlm.nih.gov/pubmed/31388451 http://dx.doi.org/10.1186/s40885-019-0121-0

Ejemplares similares

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Kim, Kwang-il, et al.
Publicado: (2019)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
por: Lee, Hae-Young, et al.
Publicado: (2019)

2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
por: Shin, Jinho, et al.
Publicado: (2015)

2013 Korean Society of Hypertension guidelines for the management of hypertension: part I–epidemiology and diagnosis of hypertension
por: Shin, Jinho, et al.
Publicado: (2015)

2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Shin, Jinho, et al.
Publicado: (2015)

The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Resistant hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kang, In Sook, et al.
Publicado: (2016)

Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension
por: Lee, Hae Young, et al.
Publicado: (2021)

Clinical and life style factors related to the nighttime blood pressure, nighttime dipping and their phenotypes in Korean hypertensive patients
por: Kim, Byung Sik, et al.
Publicado: (2023)

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

The Association between Parameters of Socioeconomic Status and Hypertension in Korea: the Korean Genome and Epidemiology Study
por: Park, Chan Soon, et al.
Publicado: (2016)

Erratum to: Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data
por: Choi, Sung Il, et al.
Publicado: (2016)

Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum
por: Ihm, Sang-Hyun, et al.
Publicado: (2022)

Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data
por: Choi, Sung Il, et al.
Publicado: (2016)

Suboptimal Management Status of Younger Hypertensive Population in Korea
por: Lee, Hae-Young, et al.
Publicado: (2021)

Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic
por: Shin, Jinho, et al.
Publicado: (2021)

Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
por: Kang, Min-gu, et al.
Publicado: (2019)

24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
por: Lee, Hae-Young, et al.
Publicado: (2017)

Potential impact of 2018 Korean Society of Hypertension guidelines on Korean population: a population-based cohort study
por: Kwun, Ju-Seung, et al.
Publicado: (2020)

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia
por: Ihm, Sang-Hyun, et al.
Publicado: (2019)

Differential Control Rate of Systolic and Diastolic Blood Pressure among Korean Adults with Hypertension: the Sixth Korean National Health and Nutrition Examination Survey, 2013–2015 (KNHANES VI)
por: Cho, So Mi Jemma, et al.
Publicado: (2019)

Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort
por: Lee, Jin Young, et al.
Publicado: (2023)

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study
por: Hong, Soon Jun, et al.
Publicado: (2020)

Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women
por: Oh, Gyu Chul, et al.
Publicado: (2018)

Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South Korea
por: Shin, Jeong‐Hun, et al.
Publicado: (2021)

Coffee intake and hypertension in Korean adults: results from KNHANES 2012–2016
por: Shah, Surabhi, et al.
Publicado: (2023)

Temporal and Geospatial Trends of Hypertension Management in Korea: a Nationwide Study 2002–2016
por: Lee, Hokyou, et al.
Publicado: (2019)

Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension
por: Chung, Wook-Jin, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program
por: Lee, Hae-Young, et al.
Publicado: (2021)

Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea
por: Kwon, Chang Hee, et al.
Publicado: (2021)

Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension
por: Sung, Ki‐Chul, et al.
Publicado: (2023)

The Korean Hypertension Cohort study: design and baseline characteristics
por: Lee, Hae-Young, et al.
Publicado: (2021)

Hypertension Control in Young Population: the Earlier, the Better
por: Pyun, Wook Bum
Publicado: (2020)

The Prevalence and Awareness of Hypertension and the Relationship between Hypertension and Snoring in the Korean Population
por: Kim, Jin Seok, et al.
Publicado: (2001)

Korea hypertension fact sheet 2018
por: Kim, Hyeon Chang, et al.
Publicado: (2018)

Office blood pressure threshold of 130/80 mmHg better predicts uncontrolled out‐of‐office blood pressure in apparent treatment‐resistant hypertension
por: Lee, Chan Joo, et al.
Publicado: (2020)

Incidence of Hypertension in Korea: 5-Year Follow-up Study
por: Lee, Jang Hoon, et al.
Publicado: (2011)

Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
por: Park, Sungha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1c7tbqdfknif55aoc9g0rnv46r